| http://www.w3.org/ns/prov#value | - Cephalon purportedly paid the firms to refrain from selling generic Provigil until 2012.The agency contended that the conduct denied patients access to lower-cost, generic versions of Provigil and forced consumers and other purchasers to pay hundreds of millions of dollars a year more for Provigil.Pay-for-Delay Settlement TacticsThe FTC contended that the conduct involved pay-for-delay settlemen
|
